z-logo
Premium
Metoprolol kinetics and dose response in hypertensive patients
Author(s) -
Myers Martin G,
Thiessen Jake J
Publication year - 1980
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1980.106
Subject(s) - metoprolol , kinetics , medicine , steady state (chemistry) , dose–response relationship , pharmacology , chemistry , physics , quantum mechanics
The kinetics and dose‐response characteristics of metoprolol were examined in a series of hypertensive patients. In 14 the elimination half‐life of metoprolol after single 100‐mg doses (4.1 ± 0.6 hr) was prolonged (p < 0.05) after 6 to 12 wk of therapy (5.6 ± 0.7 hr). In 5 patients receiving 100 mg twice daily evidence of nonlinear metoprolol kinetics emerged, because the area under the concentration‐time curve at steady state was 86.8% more (p < 0.02) than predicted from a single dose. Kinetic data from single doses of metoprolol appear to be a poor predictor of steady‐state kinetics. Single metoprolol dosage also induced a fall (p < 0.01) in blood pressure with pretreatment levels (163/108), reaching a minimum at 5 hr (133/89). During long‐term therapy incremental doses of metoprolol between 100 and 600 mg/day in 34 hypertensive patients resulted in a relatively horizontal dose‐response curve at doses above 200 mg/day. Clinical Pharmacology and Therapeutics (1980) 27 , 756–762; doi: 10.1038/clpt.1980.106

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom